Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Therapeutic Effect of Medroxyprogesterone Acetate vs. LNG-IUS in Early-stage Endometrioid Carcinoma

NCT05565573 is registered in ClinicalTrials.gov with Hua Li as lead sponsor.

NCT NCT05565573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05565573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Therapeutic Effect of Medroxyprogesterone Acetate vs. LNG-IUS in Early-stage Endometrioid Carcinoma
Lead sponsor
Hua Li
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 1, 2022
Completion date
November 1, 2025
Enrollment
148 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fertility sparing